Sep 26, 2025, 01:01 AM by User Not Found

Bio-IT World | A new classification system for recurrent ovarian cancer was developed by scientists at Lausanne University Hospital and the Ludwig Institute for Cancer Research. The system combines genomic sequencing with immune profiling to stratify patients into four immunologic subgroups, laying the groundwork for personalized therapies that could extend survival.

Sep 25, 2025, 08:55 AM by

Delivering a menu of H&E, IHC, and special stains on the Concentriq platform

Sep 25, 2025, 08:55 AM by

Sep 25, 2025, 08:55 AM by

Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder.

Sep 25, 2025, 08:55 AM by

PubHive launches Generative AI Usage Dashboard to give life sciences teams visibility, compliance, and cost control for responsible AI adoption.

Sep 25, 2025, 01:00 AM by User Not Found

Bio-IT World | National Institute of Standards and Technology (NIST) has collaborated with biotech company MilliporeSigma and the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to create a “living” reference material; the Pistoia Alliance plans to establish a new initiative to advance the safe adoption of agentic AI; and more.

Sep 25, 2025, 01:00 AM by User Not Found

Bio-IT World | National Institute of Standards and Technology (NIST) has collaborated with biotech company MilliporeSigma and the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to create a “living” reference material; the Pistoia Alliance plans to establish a new initiative to advance the safe adoption of agentic AI; and more.

Sep 24, 2025, 01:01 AM by User Not Found

Bio-IT World | Odyssey Therapeutics aims to transform the standard of care for patients suffering from autoimmune and inflammatory diseases; Dualitas will advance a portfolio of next-generation bispecific antibodies (BsAbs), including in allergic disease and autoimmune disease, and their discovery engine; and more.

Sep 22, 2025, 09:44 AM by

Hunan Huateng Pharmaceutical Co., Ltd. provides 1-Methyl-1H-Pyrazole-4-Carboxylic Acid (CAS 5952-92-1), a high-purity intermediate used in the synthesis of Aficamten (CK-274), an investigational cardiac myosin inhibitor currently in Phase 3 trials for hypertrophic cardiomyopathy.

Sep 22, 2025, 09:44 AM by

Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms

Sep 22, 2025, 09:44 AM by

New kit enables rapid, accurate titre measurement across broad range of IgG subclasses and species on Amperia platform

Sep 22, 2025, 09:44 AM by

Arkivum is delighted to announce a new partnership with PHARMASEAL, the provider of the Engility® Trial Management Platform, consisting of a Clinical Trial Management System (CTMS) and Electronic Trial Master File (eTMF).

Sep 22, 2025, 08:49 AM by

Sep 22, 2025, 08:49 AM by

Sep 22, 2025, 08:49 AM by

Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech Partners

Sep 18, 2025, 01:01 AM by User Not Found

Bio-IT World | Last month, the National Institutes for Standards and Technology (NIST) released a new Messenger RNA Research Grade Test Material. The mRNA test material is available to researchers now who will participate in an interlaboratory study to determine the material’s fitness-for-purpose as an eventual reference standard or quality control material, providing data and feedback to NIST.

Sep 17, 2025, 01:01 AM by User Not Found

Bio-IT World | Measuring hyperinsulinemia, or elevated levels of insulin, has proven to be effective in measuring metabolic health and can help show the risk of developing diseases such as Type 2 Diabetes, obesity, and heart disease. Researchers at the University of British Columbia Okanagan have developed a way to measure insulin levels using saliva, allowing for a non-invasive method without needles or lab-based blood work.

Sep 16, 2025, 16:18 PM by

AWS HealthImaging integration delivers standards-based digital pathology at enterprise scale with DICOM and Proscia’s cloud-native platform

Sep 16, 2025, 16:18 PM by

• First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures • Additional capabilities for continuous Adeno-Associated Virus (AAV) and Lentivirus (LV) production for consistent quality, performance, and scalability

Sep 16, 2025, 16:18 PM by

Sapio ELaiN is an agentic, AI–powered notebook where scientists collaborate directly with an AI co-scientist